← SynDRA
SGC-CBP30
SynDRA canonical compound SYN0079682 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CREBBP | EP300 |
| Mechanism of action | bromodomain inhibitor |
All known targets
Mechanisms of action (all sources)
- BET bromodomain inhibitor
- KAT6B INHIBITOR
- CREBBP INHIBITOR
Cross-references
Synonyms
- (s)-4-(1-(2-(3-chloro-4-methoxyphenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1h-benzo[d]imidazol-1-yl)propan-2-yl)morpholine
- 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1,2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1,3-benzodiazole
- 2-[2-(3-Chloro-4-Methoxyphenyl)ethyl]-5-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-1-[(2s)-2-(Morpholin-4-Yl)propyl]-1h-Benzimidazole
- 2LO
- C28H33ClN4O3
- GTPL7529
- SCHEMBL17512896
- CHEMBL3622373
- AOB4800
- MolPort-035-395-859
- BDBM188519
- EX-A2159
- ZINC96170456
- s7256
- RefChem:182668
- MFCD26792586
- CBP30
- orb1300573
- SCHEMBL29403969
- GLXC-03977
- NPC69514
- AKOS024458401
- CCG-269770
- NCGC00351475-07
- NCGC00351475-09
- SGC-CBP30, >=98% (HPLC)
- AC-35767
- AS-56079
- BP-25374
- HY-15826
- SW219645-1
- T6668
- F800085
- BRD-K24821794-001-01-4
Look up SGC-CBP30 in the interactive SynDRA portal →